Literature DB >> 25910959

CRTAM is negatively regulated by ZEB1 in T cells.

C Rojas-Marquez1, R Valle-Rios2, E Lopez-Bayghen3, V Ortiz-Navarrete4.   

Abstract

T cell activation leads to the induction of genes that are required for appropriate immune responses. This includes CRTAM (Class-I MHC-restricted T cell associated molecule), a protein that plays a key role in T cell development, proliferation, and generating cell polarity during activation. We previously characterized the CRTAM promoter and described how AP-1 family members are important for inducing CRTAM expression upon antigenic activation. Here, we show that CRTAM is a molecular target for ZEB1 (zinc finger E-box-binding protein), a homeodomain/Zn finger transcription factor. Overexpression of ZEB1 repressed CRTAM promoter activity, as well as endogenous CRTAM levels in human T cells. ZEB1-mediated transcriptional repression was abolished when E-box-like elements in the CRTAM promoter are mutated. In summary, ZEB1 functions as a transcriptional repressor for the CRTAM gene in both non-stimulated and stimulated T cells, thereby modulating adaptive immune responses.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CRTAM; E-box-like elements; Promoter; Repression; Transcription; ZEB1

Mesh:

Substances:

Year:  2015        PMID: 25910959     DOI: 10.1016/j.molimm.2015.03.253

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

1.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

Review 2.  CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function.

Authors:  Arata Takeuchi; Takashi Saito
Journal:  Front Immunol       Date:  2017-02-23       Impact factor: 7.561

3.  Graft-Versus-Host Disease-Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology.

Authors:  Xiaowen Liu; Zongliang Yue; Yimou Cao; Sawa Ito; Jake Y Chen; Huanmei Wu; Sophie Paczesny; Lauren Taylor; Qing Zhang; Sung W Choi; Samir Hanash
Journal:  JCO Precis Oncol       Date:  2019-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.